Lumos Pharma, Inc.
Detecting and treating growth hormone deficiency

Last updated:

Abstract:

Described herein is a new oral method for using MK-0677 for detecting growth hormone (GH) deficiency (GHD). Also described is a method of treating growth hormone (GH) deficiency (GHD) in children with a functional hypothalamic-pituitary GH axis.

Status:
Grant
Type:

Utility

Filling date:

20 Sep 2018

Issue date:

26 Jan 2021